Capital Grand Est key facts
- Capital Grand Est is a private equity firm based in Schiltigheim, France with 19 tracked portfolio companies.
- Notable positions include Apmonia Therapeutics, AdipoPharma, Emy.
About Capital Grand Est
Founded in 2012, Capital Grand Est is a private equity investment firm headquartered in Schiltigheim, France. The firm seeks to invest in Grand Est-based companies.
Capital Grand Est portfolio at a glance
19 portfolio companies are on record for Capital Grand Est, including Apmonia Therapeutics, AdipoPharma and Emy.
10 of the 19 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·The top 10 names in the book — of 19 recorded positions
- ·Watchlist + alerts for Capital Grand Est's activity
Portfolio
19 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Apmonia Therapeutics | — | ▮ | ▮ | ▮ |
| AdipoPharma | — | ▮ | ▮ | ▮ |
| Emy | — | ▮ | ▮ | ▮ |
+ 16 more companies · all 19, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about Capital Grand Est
- What companies does Capital Grand Est invest in?
- Capital Grand Est has 19 recorded portfolio companies, including Apmonia Therapeutics, AdipoPharma, Emy.
- What is Capital Grand Est's AUM?
- Capital Grand Est manages approximately $260.9M in assets.